Confronting antimicrobial resistance beyond the COVID-19 pandemic and the 2020 US election
30 September 2020
Globally, the USA has recorded the highest number of COVID-19 cases and deaths, and still needs to simultaneously respond to another looming potential pandemic. The rise in multidrug-resistant bacterial infections that are undetected, undiagnosed, and increasingly untreatable threatens the health of people in the USA and globally. In 2020 and beyond, we cannot afford to ignore antimicrobial resistance (AMR).
Further reading: The Lancet
Author(s): Steffanie A Strathdee, Sally C Davies, Jasmine R Marcelin
Effective Surveillance
Technology Database
Display your AMR Technology, Product and Service
Suppliers and Users of Technologies, Products and Services benefit from CAPI.
CAPI (Continuous AMR Partnering Initiative) unites Suppliers and Users worldwide with the aim to add to the curbing of AMR.